Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

SBRI Healthcare Launches New Competitions, with £5 Million to Invest this Year

Published: Monday, September 23, 2013
Last Updated: Monday, September 23, 2013
Bookmark and Share
Funding will be awarded in a new round of competitions under the SBRI programme to develop innovative solutions towards better health outcomes.

SBRI Healthcare, an NHS England funded initiative to develop innovative products and services that address unmet health needs, announced a it will distribute £5 million of government investment to support small business this year.

The Small Business Research Initiative (SBRI) healthcare competitions provide seed funding for the development of novel solutions to major healthcare challenges. In this new round of competitions, SBRI Healthcare  will be looking for companies specifically focused on driving towards better health outcomes for patients across seven categories; Cancer, Cardiovascular, COPD, Diabetes, Mental Health/Dementia, Patient Safety and Research Tools.

The Prime Minister’s UK Strategy for Health Innovation and Life Sciences - Innovation, Health and Wealth* (IHW) - set the approach for innovation in the reformed NHS, making a commitment to double investment in the SBRI programme to address healthcare challenges, encourage greater competition in procurement of services and drive growth in the UK Small and Medium size Enterprises (SME) sector.

Investing £17.6 million to date in support of 66 SMEs, the further £5 million in funding is recognition of the value small businesses bring to the NHS to help them deliver new technologies to patients and for these to be adopted widely across the NHS.

Miles Ayling, Director of Innovation, NHS England

“Innovation Health and Wealth set out the agenda to spread best practice across the NHS whilst at the same time supporting economic growth and wealth creation. The Small Business Research Initiative is a way for NHS England to generate a pipeline of new ideas and technologies with predominantly small to medium sized companies. The ideas in this sector are often highly innovative and exciting – bringing a step change to the way the NHS can deliver quality care for patients. In Innovation Health and Wealth the NHS set out to double the investment in SBRI – NHS England has already committed £5m this year and today’s competition launch will support industry with a further £5m investment.”

Sir Mike Rawlins, Chair of the Eastern Academic Health Science Network (EAHSN), who lead the programme on behalf of NHS England commented:

“The NHS is a great market place for new technology companies.  Through the SBRI programme we can find new ways of solving old problems – which benefit patients and support business growth.  In the NHS we have world leading clinical expertise and through programmes such as SBRI Healthcare we can work with business experts to maximise the benefit to the NHS and the economy.”

Peter Ellingworth OBE, Chair of the SBRI Management Board and Chief Executive of the Association of British Healthcare Industries welcomed the new competition:

“The med tech industry is an important success story for the UK economy. Many companies already work closely with the NHS but the SBRI programme supports new partnerships to develop and succeed. Through SBRI the companies can gain funding but also the expert support of the NHS to develop products that are truly reflecting NHS need. I hope many companies take a good look and apply for this programme.”

The competition theme areas have been chosen in partnership with the newly designated Academic Health Science Networks (AHSNs) across England. The programme management is led by the Eastern Academic Health Science Network (EAHSN) on behalf of NHS England and other AHSNs. Health Enterprise East is the management partner and supports the EAHSN to handle the applications, assessments and delivery against contracts.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Three Companies Awarded Funding in Department of Health’s SBRI Healthcare Programme
Funding awarded to develop innovative solutions that address unmet health needs.
Tuesday, July 30, 2013
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Study Questions Presence in Blood of Heart-Healthy Molecules from Fish Oil Supplements
A new study from the Perelman School of Medicine at the University of Pennsylvania questions the relevance of fish oil-derived SPMs and their purported anti-inflammatory effects in humans.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Key Player in Diabetic Kidney Disease Revealed
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!